A detailed history of Natixis Advisors, L.P. transactions in Balchem Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 21,797 shares of BCPC stock, worth $3.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,797
Previous 21,344 2.12%
Holding current value
$3.76 Million
Previous $3.29 Million 16.74%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$154.1 - $181.56 $69,807 - $82,246
453 Added 2.12%
21,797 $3.84 Million
Q2 2024

Aug 01, 2024

BUY
$138.5 - $156.63 $51,937 - $58,736
375 Added 1.79%
21,344 $3.29 Million
Q1 2024

Apr 25, 2024

BUY
$137.06 - $157.27 $411,591 - $472,281
3,003 Added 16.71%
20,969 $3.25 Million
Q4 2023

Feb 06, 2024

BUY
$115.08 - $150.35 $98,048 - $128,098
852 Added 4.98%
17,966 $2.67 Million
Q3 2023

Nov 13, 2023

BUY
$123.38 - $142.72 $64,774 - $74,928
525 Added 3.16%
17,114 $2.12 Million
Q2 2023

Aug 15, 2023

BUY
$122.28 - $136.64 $101,736 - $113,684
832 Added 5.28%
16,589 $2.24 Million
Q1 2023

May 11, 2023

BUY
$117.39 - $142.06 $41,556 - $50,289
354 Added 2.3%
15,757 $1.99 Million
Q4 2022

Jan 27, 2023

BUY
$120.16 - $142.73 $204,872 - $243,354
1,705 Added 12.45%
15,403 $1.88 Million
Q3 2022

Nov 14, 2022

BUY
$119.7 - $141.48 $308,347 - $364,452
2,576 Added 23.16%
13,698 $1.67 Million
Q2 2022

Aug 12, 2022

SELL
$113.6 - $139.82 $32,603 - $40,128
-287 Reduced 2.52%
11,122 $1.44 Million
Q1 2022

May 12, 2022

BUY
$131.21 - $167.55 $69,934 - $89,304
533 Added 4.9%
11,409 $1.56 Million
Q4 2021

Feb 08, 2022

BUY
$149.18 - $172.5 $84,435 - $97,635
566 Added 5.49%
10,876 $1.83 Million
Q3 2021

Nov 15, 2021

BUY
$129.2 - $150.61 $1.33 Million - $1.55 Million
10,310 New
10,310 $1.5 Million

Others Institutions Holding BCPC

About BALCHEM CORP


  • Ticker BCPC
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 32,120,600
  • Market Cap $5.54B
  • Description
  • Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...
More about BCPC
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.